CCL5 and ovarian carcinoma: Chemokine CCL5 has been demonstrated to desensitize ovarian cancer cells to cisplatin through expansion of cancer stem cells93, and promotes resistance to cisplatin through STAT3 and PI3K/AKT activation44.